Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Comparative, Controlled Trial of Tolerability, Safety and Immunogenicity of the Flu-M Tetra Vaccine in Children Between 6 Months and 17 Years Old

NCT05739474 is registered in ClinicalTrials.gov with St. Petersburg Research Institute of Vaccines and Sera as lead sponsor.

NCT NCT05739474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05739474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Comparative, Controlled Trial of Tolerability, Safety and Immunogenicity of the Flu-M Tetra Vaccine in Children Between 6 Months and 17 Years Old
Lead sponsor
St. Petersburg Research Institute of Vaccines and Sera
Phase
Phase 3
Overall status
Unknown status
Start date
January 19, 2022
Completion date
December 30, 2023
Enrollment
948 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, influenza viral infections, influenza, human, vaccine reaction